NEW YORK, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Exelixis, Inc. ("Exelixis" or "the Company") (NASDAQ:EXEL). Investors who purchased Exelixis securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/EXEL. Investigation Details […]

NEW YORK CITY, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Charter Communications, Inc. ("Charter" or "the Company") (NASDAQ:CHTR). Investors who purchased Charter securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CHTR.

NEW YORK CITY, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novo Nordisk A/S ("Novo Nordisk" or "the Company") (NYSE:NVO). Investors who purchased Novo Nordisk securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s

NEW YORK CITY, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Simulations Plus, Inc. ("Simulations" or "the Company") (NASDAQ:SLP). Investors who purchased Simulations securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/SLP.

NEW YORK, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Barnes & Noble Education, Inc. ("Barnes & Noble" or "the Company") (NYSE:BNED). Investors who purchased Barnes & Noble securities are encouraged to obtain additional information and assist the investigation by

NEW YORK CITY, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nutex Health, Inc. ("Nutex" or "the Company") (NASDAQ:NUTX). Investors who purchased Nutex securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NUTX.

NEW YORK, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Telix Pharmaceuticals Limited ("Telix" or "the Company") (NASDAQ:TLX). Investors who purchased Telix securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/TLX. Investigation

NEW YORK CITY, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Replimune Group, Inc. ("Replimune" or "the Company") (NASDAQ:REPL). Investors who purchased Replimune securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/REPL.

NEW YORK CITY, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Geely Automobile Holdings Limited ("Geely" or "the Company") (OTCMKTS:GELYF)(OTCMKTS:GELYY). Investors who purchased Geely securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:

NEW YORK CITY, NY / ACCESS Newswire / August 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Geely Automobile Holdings Limited ("Geely" or "the Company") (OTCMKTS:GELYF; GELYY). Investors who purchased Geely securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s